Please wait a minute...
文章检索
预防医学  2023, Vol. 35 Issue (9): 757-761    DOI: 10.19485/j.cnki.issn2096-5087.2023.09.005
  论著 本期目录 | 过刊浏览 | 高级检索 |
早产儿呼吸窘迫综合征肺表面活性物质治疗两种给药方法比较
张艳丽1, 朱鹏2, 杨蓉1, 王鑫鑫1, 尹晓光1
1.安徽省妇幼保健院新生儿科,安徽 合肥 230001;
2.安徽医科大学公共卫生学院,安徽 合肥 230032
Comparison of the effectiveness of two pulmonary surfactant administration methods among premature infants with respiratory distress syndrome
ZHANG Yanli1, ZHU Peng2, YANG Rong1, WANG Xinxin1, YIN Xiaoguang1
1. Department of Neonatology, Anhui Provincial Maternity and Child Health Hospital, Hefei, Anhui 230001, China;
2. School of Public Health, Anhui Medical University, Hefei, Anhui 230032, China
全文: PDF(825 KB)  
输出: BibTeX | EndNote (RIS)      
摘要 目的 比较微创肺表面活性物质(PS)给药(LISA)和气管插管-PS给药-拔管(INSURE)治疗早产儿呼吸窘迫综合征(RDS)的效果,为提高早产儿RDS治疗效果、减少并发症提供参考。方法 选择安徽省妇幼保健院治疗的RDS早产儿71例,随机纳入LISA组和INSURE组,实施基础支持治疗和呼吸支持治疗,分别采用LISA和INSURE给药方法行PS治疗。比较两组患儿的一般资料、治疗前后动脉血气分析、呼吸支持时间和并发症发生率。结果 LISA组31例,胎龄为(29.81±0.99)周,男婴22例;INSURE组40例,胎龄为(30.02±1.13)周,男婴26例。两组患儿胎龄、出生体重、性别等一般资料比较,差异均无统计学意义(P>0.05)。治疗后,LISA组PaO2为(78.35±6.55)mmHg,低于INSURE组的(87.68±8.21)mmHg(P<0.05);PaCO2为(43.03±6.34)mmHg,高于INSURE组的(38.68±9.69)mmHg(P<0.05);支气管肺发育不良发生率为48.39%,低于INSURE组的72.50%(P<0.05);线性回归分析结果显示随着LISA给药时间延长(2~7 min),患儿最低心率呈线性增高(β=13,P<0.05)。结论 相较于INSURE,LISA给药治疗可缓慢改善RDS早产儿通气氧合,减少过度通气,降低支气管肺发育不良发生率;且适当延长给药时间可降低心率减慢发生率。
服务
把本文推荐给朋友
加入引用管理器
E-mail Alert
RSS
作者相关文章
张艳丽
朱鹏
杨蓉
王鑫鑫
尹晓光
关键词 早产儿呼吸窘迫综合征微创肺表面活性物质给药气管插管-肺表面活性物质给药-拔管    
AbstractObjective To compare the effectiveness of less invasive surfactant administration (LISA) and intubate surfactant extubation (INSURE) on respiratory distress syndrome (RDS) among premature infant, so as to provide insights into improving treatment effects and reducing complications of RDS among premature infants. Methods A total of 71 premature infants with RDS in Anhui Provincial Maternity and Child Health Hospital were randomly assigned into the LISA and INSURE group, and pulmonary surfactant (PS) administration was carried out by LISA and INSURE with basic support therapy and respiratory support therapy. The general information, arterial blood gas analysis before and after treatment, respiratory support time and incidence of complications were collected and compared between the two groups. Results There were 31 cases in the LISA group, with a gestational age of (29.81±0.99) weeks and 22 male cases, and 40 cases in the INSURE group, with a gestational age of (30.02±1.13) weeks and 26 male cases. There were no significant differences in basic characteristics (including gestational age, birth weight, gender, etc.) between the two groups (all P>0.05). After administration, the level of PaO2 was lower in the LISA group than in the INSURE group [(78.35±6.55) mmHg vs. (87.68±8.21) mmHg, P<0.05], the level of PaCO2 was higher in the LISA group than in the INSURE group [(43.03±6.34) mmHg vs. (38.68±9.69) mmHg, P<0.05], and the incidence of bronchopulmonary dysplasia was lower in the LISA group than in the INSURE group (48.39% vs. 72.50%, P<0.05). Linear regression analysis showed that with the duration of LISA administration increase (2-7 min), the minimum heart rate of premature infants increased linearly (β=13, P<0.05). Conclusions Compared with INSURE, LISA administration could slowly improve ventilation oxygenation, reduce hyperventilation and incidence of bronchopulmonary dysplasia among premature infants with RDS. The incidence of slow heart rate may be reduced by appropriately prolonging the administration duration.
Key wordspremature infant    respiratory distress syndrome    less invasive surfactant administration    intubate surfactant extubate
收稿日期: 2023-06-28      修回日期: 2023-08-02      出版日期: 2023-09-10
中图分类号:  R722.6  
基金资助:国家自然科学基金面上项目(82173531); 合肥市卫生健康委员会2021年度应用医学研究项目(HWK2021yb016)
通信作者: 尹晓光,E-mail:323159507@qq.com   
作者简介: 张艳丽,硕士,主治医师,主要从事新生儿常见疾病诊治工作
引用本文:   
张艳丽, 朱鹏, 杨蓉, 王鑫鑫, 尹晓光. 早产儿呼吸窘迫综合征肺表面活性物质治疗两种给药方法比较[J]. 预防医学, 2023, 35(9): 757-761.
ZHANG Yanli, ZHU Peng, YANG Rong, WANG Xinxin, YIN Xiaoguang. Comparison of the effectiveness of two pulmonary surfactant administration methods among premature infants with respiratory distress syndrome. Preventive Medicine, 2023, 35(9): 757-761.
链接本文:  
http://www.zjyfyxzz.com/CN/10.19485/j.cnki.issn2096-5087.2023.09.005      或      http://www.zjyfyxzz.com/CN/Y2023/V35/I9/757
[1] MWITA S,JANDE M,KATABALO D,et al.Reducing neonatal mortality and respiratory distress syndrome associated with preterm birth:a scoping review on the impact of antenatal corticosteroids in low-and middle-income countries[J].World J Pediatr,2021,17(2):131-140.
[2] 翁生良,王伟燕.无创高频振荡通气在新生儿呼吸衰竭治疗中的应用进展[J].预防医学,2022,34(6):586-589.
[3] SWEET D G,CARNIELLI V,GREISEN G,et al.European consensus guidelines on the management of respiratory distress syndrome-2019 update[J].Neonatology,2019,115(4):432-451.
[4] HERTING E,HRTEL C,GPEL W.Less invasive surfactant administration:best practices and unanswered questions[J].Curr Opin P ediatr,2020,32(2):228-234.
[5] VENTO G,VENTURA M L,PASTORINO R,et al.Lung recruitment before surfactant administration in extremely preterm neonates with respiratory distress syndrome(IN-REC-SUR-E):a randomised,unblinded,controlled trial[J].Lancet Respir Med,2021,9(2):159-166.
[6] SHETTY S,EGAN H,CORNUAUD P,et al.Less invasive surfactant administration in very prematurely born infants[J].AJP Rep,2021,11(3):119-122.
[7] 邵肖梅,叶鸿瑁,丘小汕.实用新生儿学[M].5版.北京:人民卫生出版社,2018.
[8] 刘慧强,童笑梅,韩彤妍,等.微创应用肺表面活性物质治疗早产儿呼吸窘迫综合征的多中心临床研究[J].中华儿科杂志,2020,58(5):374-380.
[9] BOHLIN K,BOUHAFS RK,JARSTRAND C,et al.Spontaneous breathing or mechanical ventilation alters lung compliance and tissue association of exogenous surfactant in preterm newborn rabbits[J].Pediatr Res,2005,57:624-630.
[10] RICCI F,BRESESTI I,et al.Surfactant lung delivery with LISA and INSURE in adult rabbits with respiratory distress[J].Pediatr Res,2021,90(3):576-583.
[11] BELLOS I,FITROU G,PANZA R,et al.Comparative efficacy of methods for surfactant administration:a network meta analysis[J].Arch Dis Child Fetal Neonatal Ed,2021,106(5):474-487.
[12] URSZULA K,EWA G.The influence of the technique of surfactant administration(LISA vs INSURE)on the outcomes of respiratory distress syndrome treatment in preterm infants[J].DEV Period Med,2019,23(3):163-171.
[13] DE LUCA D,SHANKAR-AGUILERA S,CENTORRINO R,et al.Less invasive surfactant administration:a word of caution[J].Lancet Child Adolesc Health,2020,4(4):331-340.
[14] DE LUCA D,SHANKAR-AGUILERA S,BANCALARI E.LISA/MIST:complex clinical problems almost never have easy solutions[J/OL].Semin Fetal Neonatal Med,2021,26(2)[2023-08-02].https://doi.org/10.1016/j.siny.2021.101230.
[1] 门光国, 鲁徐丹, 王丽丽. 初乳对早产儿免疫球蛋白A水平影响的Meta分析[J]. 预防医学, 2023, 35(5): 431-435,439.
[2] 余红, 陈晓霞, 吴长划, 沈沛. 早产儿体格生长和神经发育的早期综合干预效果评价[J]. 预防医学, 2022, 34(8): 771-775.
[3] 李如霞, 王楸, 曹肃婷, 张昌静. 早产儿维生素D水平及影响因素分析[J]. 预防医学, 2019, 31(8): 848-850.
[4] 雷宗峰, 周玉润, 韩影, 孙建乐, 闫洪涛, 杨新军. 孕期温度暴露与早产儿发生的关联性研究[J]. 预防医学, 2019, 31(6): 631-633,636.
[5] 陆斌, 徐春思, 任艳红, 冯佳, 史彩平. 早产与足月出生近视幼儿眼球生物学测量结果比较[J]. 预防医学, 2019, 31(3): 309-310,313.
[6] 朱艳可, 孙媛媛, 缪克凡, 王楸. 早产儿支气管肺发育不良影响因素分析[J]. 预防医学, 2019, 31(10): 1051-1053.
[7] 周玉润, 林颖, 孙建乐, 陈洋. 温州市3 625例早产儿体格生长状况分析[J]. 预防医学, 2017, 29(7): 740-743,747.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed